rs2252576
Positions:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1
The NM_012105.5(BACE2):c.748-10C>T variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.253 in 1,578,428 control chromosomes in the GnomAD database, including 61,160 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.36 ( 13983 hom., cov: 32)
Exomes 𝑓: 0.24 ( 47177 hom. )
Consequence
BACE2
NM_012105.5 splice_polypyrimidine_tract, intron
NM_012105.5 splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.00001374
2
Clinical Significance
Conservation
PhyloP100: 0.359
Genes affected
BACE2 (HGNC:934): (beta-secretase 2) This gene encodes an integral membrane glycoprotein that functions as an aspartic protease. The encoded protein cleaves amyloid precursor protein into amyloid beta peptide, which is a critical step in the etiology of Alzheimer's disease and Down syndrome. The protein precursor is further processed into an active mature peptide. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 21-41243366-C-T is Benign according to our data. Variant chr21-41243366-C-T is described in ClinVar as [Benign]. Clinvar id is 3059580.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.715 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BACE2 | NM_012105.5 | c.748-10C>T | splice_polypyrimidine_tract_variant, intron_variant | ENST00000330333.11 | NP_036237.2 | |||
BACE2 | NM_138991.3 | c.748-10C>T | splice_polypyrimidine_tract_variant, intron_variant | NP_620476.1 | ||||
BACE2 | NM_138992.3 | c.748-10C>T | splice_polypyrimidine_tract_variant, intron_variant | NP_620477.1 | ||||
BACE2 | XM_017028314.2 | c.463-10C>T | splice_polypyrimidine_tract_variant, intron_variant | XP_016883803.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BACE2 | ENST00000330333.11 | c.748-10C>T | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_012105.5 | ENSP00000332979 | P1 |
Frequencies
GnomAD3 genomes AF: 0.363 AC: 55071AN: 151858Hom.: 13951 Cov.: 32
GnomAD3 genomes
AF:
AC:
55071
AN:
151858
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.235 AC: 54424AN: 231610Hom.: 8904 AF XY: 0.228 AC XY: 28532AN XY: 125302
GnomAD3 exomes
AF:
AC:
54424
AN:
231610
Hom.:
AF XY:
AC XY:
28532
AN XY:
125302
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.241 AC: 343972AN: 1426452Hom.: 47177 Cov.: 30 AF XY: 0.238 AC XY: 168736AN XY: 707658
GnomAD4 exome
AF:
AC:
343972
AN:
1426452
Hom.:
Cov.:
30
AF XY:
AC XY:
168736
AN XY:
707658
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.363 AC: 55148AN: 151976Hom.: 13983 Cov.: 32 AF XY: 0.354 AC XY: 26273AN XY: 74292
GnomAD4 genome
AF:
AC:
55148
AN:
151976
Hom.:
Cov.:
32
AF XY:
AC XY:
26273
AN XY:
74292
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
604
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
BACE2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 30, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at